Abstract
Haematoporphyrin derivative (HPD) photodynamic therapy (PDT) may have clinical application in the management of patients with retinoblastoma. Heterotransplantation of retinoblastoma cells into the anterior chamber of the nude mouse eye and the subsequent growth of small tumour masses has provided a model for evaluation of various therapeutic modalities. Ninety-four evaluable xenograft tumours in 54 nude mice were randomized to receive one of the following treatments: cyclophosphamide (CPM) alone, HPD-PDT alone, CPM followed by HPD-PDT, HPD-PDT followed by CPM, or saline control. Responses were demonstrated after CPM treatment in all three relevant groups. However, HPD-PDT was found to be ineffective either alone or as a contributor in the double modality treatment groups. The small tumour masses treated can be demonstrated histologically to be avascular. It is proposed that although the same retinoblastoma cells in different circumstances are responsive to HPD-PDT, no clinical response is demonstrable utilizing this model, due to the absence of tumor vascularity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
White, L., Gomer, C., Doiron, D. et al. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Br J Cancer 57, 455–458 (1988). https://doi.org/10.1038/bjc.1988.106
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.106
This article is cited by
-
Retinoblastoma: might photodynamic therapy be an option?
Cancer and Metastasis Reviews (2015)
-
Photodynamische Therapie mit Verteporfin beim Aderhautmelanom
Der Ophthalmologe (2005)
-
Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model
Journal of Neuro-Oncology (1995)